"A Phase II trial assessing the efficacy and safety of OPC-34712 in the acute treatment of adult schizophrenia (Study 331-07-203)"; presented at 24th Annual US Psychiatric and Mental Health Congress, 7-11 November 2011, Las Vegas, NV, USA [iii]Thase, M.E., Hobart, M, Augustine, C., Youakim, J.M., Zhang, P., Hefting, N., et al: